Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 17 matching records.
17 results — page 1 of 1
- Level DAnimal StudyPubMed
Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis.
Animal Study on Osteoarthritis, Cartilage Damage, Neuroinflammation, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DAnimal StudyEurope PMC
Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model
Animal Study, published in Biomedicines (2023) — summary generated from the PubMed abstract.
- 2023
Biomedicines6 citations - Level DNarrative ReviewEurope PMC
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
Narrative Review, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther7 citations - Level DNarrative ReviewEurope PMC
Considerations in the Design of Non-Clinical Development Programmes to Support Non-Viral Genetically Modified Mesenchymal Stromal Cell Therapies
Narrative Review, published in Pharmaceutics (2021) — summary generated from the PubMed abstract.
- 2021
Pharmaceutics2 citations - Level CProspective StudyPubMed
Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
Prospective Study, published in Cells (2019) — summary generated from the PubMed abstract.
- 2019
Cells54 citations - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther36 citations - Level DAnimal StudyPubMed
Sustained release of TGF-β1 via genetically-modified cells induces the chondrogenic differentiation of mesenchymal stem cells encapsulated in alginate sulfate hydrogels.
Animal Study, published in J Mater Sci Mater Med (2018) — summary generated from the PubMed abstract.
- 2018
J Mater Sci Mater Med - Level BClinical TrialPubMed
Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
Clinical Trial on Systemic / IV, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyPubMed
Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells.
Animal Study, published in Stem Cells Dev (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Dev - Level DAnimal StudyPubMed
Implant Composed of Demineralized Bone and Mesenchymal Stem Cells Genetically Modified with AdBMP2/AdBMP7 for the Regeneration of Bone Fractures in Ovis aries .
Animal Study, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int11 citations - Level DAnimal StudyPubMed
Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
Animal Study on Systemic / IV, published in Immunol Invest (2015) — summary generated from the PubMed abstract.
- 2015
Immunol Invest12 citations - Level DNarrative ReviewPubMed
The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cell Rev Rep19 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.
Animal Study on Chronic Inflammation, Immune Modulation, published in Cytotherapy (2012) — summary generated from the PubMed abstract.
- 2012
Cytotherapy25 citations - Level CProspective StudyPubMed
Analysis of biodistribution and engraftment into the liver of genetically modified mesenchymal stromal cells derived from adipose tissue.
Prospective Study on Scar, published in Cell Transplant (2012) — summary generated from the PubMed abstract.
- 2012
Cell Transplant - Level DAnimal StudyPubMed
Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice.
Animal Study, published in Exp Hematol (2011) — summary generated from the PubMed abstract.
- 2011
Exp Hematol - Level CProspective StudyPubMed
Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue.
Prospective Study on Chronic Wound, published in Tissue Eng (2005) — summary generated from the PubMed abstract.
- 2005
Tissue Eng250 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406